Arkolith/Insider Trading/FRTX/Form 4

Exploration Capital, LLC

10% OwnerFresh Tracks Therapeutics, Inc. (FRTX) · full profile →Form 4 · filed Apr 5, 2024
Net Buying
Open-Market Buys
$16K
Open-Market Sells
$0
Net Open-Market Flow
$16K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 5, 2024Buy(P)1K$0.91$9561.0M
Apr 4, 2024Buy(P)3K$0.91$3K1.0M
Apr 3, 2024Buy(P)13K$0.91$12K1.0M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-24-030877) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML